Baber, U., Cao, D., Collier, T., Sartori, S., Dangas, G., Angiolillo, D. J., Vogel, B., Kunadian, V., Briguori, C., Cohen, D. J., Dudek, D., Gibson, C. M., Gil, R., Huber, K., Kaul, U., Kornowski, R., Krucoff, M. W., Mehta, S., Moliterno, D. J., … Mehran, R. (2024). Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial. European Heart Journal - Cardiovascular Pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvae080

Dehghani, P., Cao, D., Baber, U., Nicolas, J., Sartori, S., Pivato, C. A., Zhang, Z., Dangas, G., Angiolillo, D. J., Briguori, C., Cohen, D. J., Collier, T., Dudek, D., Gibson, M., Gil, R., Huber, K., Kaul, U., Kornowski, R., Krucoff, M. W., … Mehran, R. (2022). Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD. European Heart Journal - Cardiovascular Pharmacotherapy, 8(7), 707–716. https://doi.org/10.1093/ehjcvp/pvac016